Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma

Xinguo Zhuang(First Affiliated Hospital of Xiamen University), Bing Xu(First Affiliated Hospital of Xiamen University)
International Journal of Medical Sciences
November 15, 2023
Cited by 1


Related Papers